RT @MeralElRamahiMD: Do you increase spacing of TNF-i administration in your patients with axSpA with sustained low dise
Tweet Content
Do you increase spacing of TNF-i administration in your patients with axSpA with sustained low disease activity for one year? OP0138 results showed similar relapse rates in those with increased spacing intervals and those on standard dosing regimen. #EULAR2021 @RheumNowNews
Show on Archive Page
On
Display in Search Results
On
PDQ
Off